Aug 2026· Progress in Neuro-psychopharmacology and Biological Psychiatry· Vol 149, pp.
111872
· 0 citations· 101 references
Medicine
TL;DR
A complete synthesis of the current scenario and future perspectives on data availability towards enhanced reliability, transparency, and applicability of AI-driven depression diagnostics is served as a complete synthesis of the current scenario and future perspectives on data availability.
Abstract
Depression is a widespread mental illness in which there is a noticeable difference in the quality of life of people. Electroencephalography (EEG) seems to be a promising non-invasive measurement for depression detection based on brain activity patterns. Recently, various deep learning approaches have been widely utilized in EEG data, enhancing accuracy and automation in depression detection. However, the inherent nature of deep learning models as a black box poses a challenge for their implementation in clinical practice, and thus interpretability would be a crucial part. This systematic review of the literature discusses more than 100 peer-reviewed selected studies published between 2017 and 2026, focusing on EEG-based depression detection using deep learning and interpretability methods. The review addresses multiple kinds of models, like convolutional neural networks, long short-term memory networks, and hybrid architectures, as well as interpretability approaches like shapley additive explanations (SHAP), local interpretable model-agnostic explanation (LIME), and attention mechanisms. Deep learning models are mostly identified to efficiently capture spatio-temporal EEG features without proper development in the adoption of interpretability techniques. Further challenges, however, are found in dataset limitations, non-uniformity in preparation and evaluation conditions, and barriers toward eventual clinical integration. Thus, this review serves as a complete synthesis of the current scenario and future perspectives on data availability towards enhanced reliability, transparency, and applicability of AI-driven depression diagnostics.
Depression is one of the most widespread mental health conditions worldwide and impacts approximately 280 million people around the globe. The primary way to diagnose and treat depressive disorders is through clinical interviews and predominantly self-reports, which are very subjective, often very time and labor intens...
Veerpal Kaur· Natural Resources for Human...· 0 citations
This review delivers a comprehensive analysis of the 69 published articles from 2020 to 2026 that exhibit ML/DL methods for recognizing depression based on EEG and ERP datasets and provides guidance for researchers in this field by pointing out challenges, research gaps, and suggestions for future directions.
Atefeh Abedzadeh Attar, M. Moattar, E. Kheirkhah· Discover Artificial Intellig...· 0 citations
A narrative review examines recent studies on depression assessment from three major perspectives: physiological signals, behavioral signals, and multimodal fusion, highlighting how different data modalities capture complementary aspects of depressive states.
This is the first study to integrate EEG and ERP data in a multimodal fashion using three feature sets, achieving a high accuracy of 91% with GRU‐based classification and indicates that the combination of multimodal features and deep learning can help improve the accuracy of depression diagnosis and develop effective a...
Atefeh Abedzadeh Attar, M. Moattar, Y. Forghani· Applied AI Letters· 0 citations
This survey provides a comprehensive synthesis of EEG-based dementia studies published between 2020 and 2025, with a primary focus on Alzheimer’s disease, frontotemporal dementia (FTD), mild cognitive impairment (MCI), and related dementia disorders.
Oluwatoyin Kode, Mitch Hong, Long Nguyen et al.· ET Journal· 0 citations
This study evaluates whether subject-wise cross-validation and multi-method explainability analysis can yield reproducible and neurophysiologically interpretable deep learning models for EEGbased schizophrenia detection. Schizophrenia is a severe psychiatric disorder for which no objective neurophysiological biomarker...
Burcu Çarklı Yavuz· Sakarya University Journal o...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.